Pursuit Wealth Management’s AstraZeneca AZN Stock Holding History

Pursuit Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$636K	Buy	+3,459	New	+$607K	0.55%	64

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Pursuit Wealth Management's AZN Position: Q4 2025 in Review

Pursuit Wealth Management opened a new position in AstraZeneca (AZN) in Q4 2025: 3,459 shares worth $636K. The stake represents 0.55% of the portfolio and ranks #64 among its holdings.

1,406 funds tracked by Wall St. Rank hold AZN as of Q4 2025.

Pursuit Wealth Management held 3,459 shares of AstraZeneca worth $636K as of Q4 2025.
AstraZeneca was a new Pursuit Wealth Management position in Q4 2025.
AstraZeneca made up 0.55% of Pursuit Wealth Management's portfolio in Q4 2025, its #64 holding.
1,406 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.

Based on Pursuit Wealth Management's 13F filing for Q4 2025, filed 26 Jan 2026.